Italia markets closed

Harmony Biosciences Holdings, Inc. (HRMY)

NasdaqGM - NasdaqGM Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
31,57-0,12 (-0,38%)
Alla chiusura: 04:00PM EDT
31,57 0,00 (0,00%)
Dopo ore: 04:03PM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente31,69
Aperto31,79
Denaro31,48 x 100
Lettera31,59 x 100
Min-Max giorno31,23 - 32,37
Intervallo di 52 settimane18,61 - 39,26
Volume535.375
Media Volume420.545
Capitalizzazione1,793B
Beta (5 anni mensile)0,73
Rapporto PE (ttm)13,61
EPS (ttm)2,32
Prossima data utili30 lug 2024 - 05 ago 2024
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendoN/D
Stima target 1A42,25
  • GlobeNewswire

    Harmony Biosciences Reports Second Quarter 2023 Financial Results and Business Updates

    WAKIX® (pitolisant) Net Revenue Increased ~25% Year-over-Year to $134.2 Million for Second Quarter 2023 Average Number of Patients on WAKIX Increased by ~350 Sequentially to ~5,450 for Second Quarter 2023 Exited Second Quarter 2023 With ~5,600 Patients on WAKIX Completed Enrollment in Phase 3 Idiopathic Hypersomnia (IH) INTUNE Study; On-track for Topline Data in Fourth Quarter 2023 Plans to Initiate Prader-Willi Syndrome (PWS) Phase 3 Study in Fourth Quarter 2023 Board of Directors Authorized $1